European & Developing Countries Clinical Trials Partnership

EDCTP是欧洲、撒哈拉以南非洲和欧盟国家之间的公共-公共伙伴关系。目前作为EDCTP协会成员参加EDCTP的国家有：14个欧洲国家--奥地利、丹麦、芬兰、法国、德国、爱尔兰、意大利、卢森堡、荷兰、挪威、葡萄牙、西班牙、瑞典、英国；14个非洲国家--布基纳法索、喀麦隆、刚果、加蓬、冈比亚、加纳、马里、莫桑比克、尼日尔、塞内加尔、南非、坦桑尼亚、乌干达和赞比亚。EDCTP资助的所有项目都是与撒哈拉以南国家合作开展的。EDCTP旨在支持合作研究，加速开发新的或改进的医疗干预措施，以预防或治疗撒哈拉以南非洲的艾滋病毒/艾滋病、结核病、疟疾和被忽视的传染病。EDCTP包括下列被忽视的传染病：登革热；狂犬病；人类非洲锥虫病(昏睡病)；利什曼病；囊虫病/绦虫病；麦地那龙线虫病(几内亚线虫病)；包虫病；食源性吸虫病；淋巴丝虫病；盘尾丝虫病；盘尾丝虫病；血吸虫病；土壤传播的蠕虫病；布鲁里溃疡；麻风(汉森病)；沙眼；雅司氏病；痢疾；下呼吸道感染；以及与非洲有特殊关系的新出现的传染病，如埃博拉。该方案支持关于PRDS的临床试验和相关研究活动，以及撒哈拉以南非洲的临床试验和相关研究的能力建设。EDCTP2支持所有阶段的临床试验(第一阶段至第四阶段)，以进行新的或改进的医疗干预措施，以及新诊断工具的先进测试和现场验证。有关更多信息，请访问EDCTP网站：http://www.edctp.org/

EDCTP is a public-public partnership between countries in Europe, sub-Saharan Africa and the European Union. The countries currently participating in EDCTP as members of the EDCTP Association are:14 European countries – Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, UK; and14 African countries – Burkina Faso, Cameroon, Congo, Gabon, The Gambia, Ghana, Mali, Mozambique, Niger, Senegal, South Africa, Tanzania, Uganda and Zambia.MRC contributes annually to this funding partnership to support EDCTP research and capacity building activities. All EDCTP-funded projects are undertaken in partnership with sub-Saharan countries. EDCTP aims to support collaborative research that accelerates the clinical development of new or improved medical interventions to prevent or treat HIV/AIDS, tuberculosis, malaria and neglected infectious diseases in sub-Saharan Africa.EDCTP includes the following neglected infectious diseases: dengue; rabies; human African trypanosomiasis (sleeping sickness); Leishmaniases; cysticercosis/ taeniasis; dracunculiasis (guinea-worm disease); echinococcosis; foodborne trematodiases; lymphatic filariasis; onchocerciasis (river blindness); schistosomiasis; soil-transmitted helminthiases; Buruli ulcer; leprosy (Hansen disease); trachoma; yaws; diarrhoeal infections; lower respiratory infections; as well as emerging infectious diseases of particular relevance for Africa, such as Ebola. The programme supports clinical trials and related research activities on PRDs, as well as capacity development for clinical trials and related research in sub-Saharan Africa. EDCTP2 supports all phases of clinical trials (phases I to IV) for new or improved medical interventions, as well as advanced testing and field validation of new diagnostic tools.Further information can be found on the EDCTP website: http://www.edctp.org/